Abstract
Sudden infant death syndrome (SIDS) and sudden intrauterine unexpected death syndrome (SIUDS) are an unresolved teaser in the social–medical and health setting of modern medicine and are the result of multifactorial interactions. Recently, prenatal exposure to environmental contaminants has been associated with negative pregnancy outcomes, and verification of their presence in fetal and newborn tissues is of crucial importance. A gas chromatography–tandem mass spectrometry (MS/MS) method, using a triple quadrupole analyzer, is proposed to assess the presence of 20 organochlorine pesticides, two organophosphate pesticides, one carbamate (boscalid), and a phenol (bisphenol A) in human brain tissues. Samples were collected during autopsies of infants and fetuses that died suddenly without any evident cause. The method involves a liquid–solid extraction using n-hexane as the extraction solvent. The extracts were purified with Florisil cartridges prior to the final determination. Recovery experiments using lamb brain spiked at three different concentrations in the range of 1–50 ng g-1 were performed, with recoveries ranging from 79 to 106 %. Intraday and interday repeatability were evaluated, and relative standard deviations lower than 10 % and 18 %, respectively, were obtained. The selectivity and sensitivity achieved in multiple reaction monitoring mode allowed us to achieve quantification and confirmation in a real matrix at levels as low as 0.2–0.6 ng g-1. Two MS/MS transitions were acquired for each analyte, using the Q/q ratio as the confirmatory parameter. This method was applied to the analysis of 14 cerebral cortex samples (ten SIUDS and four SIDS cases), and confirmed the presence of several selected compounds.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Sudden intrauterine unexpected death syndrome (SIUDS) and sudden infant death syndrome (SIDS) are still main medical and social challenges in developed countries. SIUDS is defined as the unexpected death of an apparently healthy fetus after the 25th week of pregnancy in the absence of infections or malformations. SIDS is the sudden death of an infant younger than 1 year of age, and which remains unexplained even after an investigation of the circumstances of death. This investigation includes a complete autopsy, an examination of the death scene, and a review of the infant’s clinical history. Several factors play important roles in the occurrence of these deaths, including genetic alterations and exposure to certain risk factors, such as maternal smoking, alcohol abuse, and drug abuse. The exposure to these risk factors has been related to an increase in the risk of SIDS and SIUDS, yielding phenotypes prone to these syndromes [1–8]. However, in many cases the exposure to those risk factors has not been proved, and new studies have been directed to the adverse effects of environmental pollution. Most of the studies have been focused on specific classes of compounds, such as organochlorine pesticides (OCPs), polybrominated diphenyl ethers, and polychlorinated biphenyls, because they are highly resistant to degradation, are lipophilic, and tend to bioaccumulate in adipose tissues and be biomagnified in the food chain. Although their use and production have been banned or restricted by the Stockholm Convention [9], these compounds are ubiquitously dispersed in the environment. During pregnancy, when fat is mobilized, the accumulated chemicals can easily cross the placenta and enter the fetal bloodstream. Once there, they can lead to several pregnancy outcomes, such as miscarriage, preeclampsia, reduced birth weight, growth retardation, and psychomotor and cognitive dysfunctions [10–16]. As a result, many current efforts are focused on the study of transplacental transfers of these classes of compounds, and on their determination in umbilical cord blood, serum, and maternal adipose tissues, to understand better the dynamics of in utero exposure [17–23]. Chemicals can also pass from breast milk to newborns, exposing them to high concentrations [24]. Some compounds, such as organophosphate pesticides (OPPs), boscalid, and bisphenol A (BPA) are considered nonpersistent in the environment, but nevertheless they are used and produced in such great quantities that the population is continuously exposed to them, although at a low concentration [25]. OPPs and boscalid are the most widely used insecticides available today and are used in agriculture, homes, gardens, and veterinary practice. BPA is an industrial chemical used to make hard clear plastic known as polycarbonate, which is used in many consumer products, including reusable bottles and baby bottles. It is a pseudopersistent chemical, which despite its short half-life is ubiquitous in the environment, where it is continuously released. Several recent studies have associated adverse health outcomes in newborns with maternal exposure to OPPs and BPA during gestation, including abnormal reflexes, reduced cognitive abilities, and attention problems [26–30]. Moreover, these compounds are reported to cross the placenta, posing a threat during brain development of the fetus [31, 32]. Although many studies on transplacental transfer have been performed, very few studies on the detection of environmental contaminants in fetal tissues have been reported [33–38]. In addition, none of these studies concern the determination of pollutants in fetal and newborn brain tissues. In light of all these factors, the assessment of fetal exposures, together with the determination of environmental contaminants in brain tissues collected from SIUDS and SIDS victims, is key to help identify a possible relationship with the abnormalities commonly found in the autonomic nervous system in both syndromes [39, 40]. All these articles describe methods based mainly on gas chromatography (GC)–mass spectrometry (MS), used in both ionization modes (electron ionization and negative chemical ionization) and GC–MS/MS. Our research group previously reported a GC–MS method for the extraction, identification, and quantification of 25 selected endocrine-disrupting compounds in liver and brain tissues from SIDS and SIUDS victims [41]. We demonstrated its ability to identify and quantify selected compounds, allowing their determination in several brain and liver tissues. Although GC–MS has been the most widely used technique for the determination of these specific compounds owing to its extreme reliability and simplicity, it may present deficiencies in ultratrace analysis of complex matrices such as biological tissues.
Therefore, owing to the very low amount of these environmental contaminants and the complexity of the matrix, it is necessary to improve further both sensitivity and selectivity. In view of the aforementioned facts, a new analytical method was developed using a GC–MS/MS instrument with a triple quadrupole (QqQ) analyzer. The use of GC–MS/MS rather than GC–MS allowed us to obtain approximately a tenfold improvement of the limits of detection (LODs). The method allowed us to improve selectivity and sensitivity, and to better confirm the actual presence of 20 OCPs, two OPPs, BPA, and boscalid in cerebral cortex of human fetal and newborn SIUDS and SIUD victims. Two OPPs, chlorpyrifos and chlorfenvinfos, and boscalid were chosen according to the use of pesticides in common Italian and European agricultural crops, such as peaches, oranges, and grapes [42–44]. We decided to include a large number of OCPs since they are the most studied compounds in maternal tissues and their significant toxicity is well documented in the literature [17, 20–23]. The use of a QqQ analyzer leads to adequate precursor and product ion selection, and allows one to increase the specificity and to minimize or eliminate matrix interferences. The use of multiple reaction monitoring (MRM) mode offers greater sensitivity compared with selected ion monitoring, because the fragmentation reaction implies two different characteristics of the target compounds [45]. Thanks to these properties, the use of MRM also ,makes it possible to simplify the cleanup procedure.
All analyses were conduced in samples from fetuses that died after the 25th week of pregnancy and SIDS victims (from 1 h to 12 months of life) from three intensive agricultural areas in northern Italy. The entire method addressed the main requirements for the proper application of national Italian law number 31/2006, “Regulations for diagnostic postmortem investigation in victims of SIDS and unexpected fetal death,” which was approved on February 2, 2006 [46]. This Italian law states that all infants that died suddenly within the first year of life of suspected SIDS and all fetuses that died after the 25th gestational week without any apparent cause must undergo an in-depth anatomopathological examination, particularly of the autonomic nervous system [47, 48]. For each autopsy, a portion of cerebral cortex (1 cm3, approximately) was collected. For ethical reasons and because of the scarce availability of real samples, all validation experiments were conducted using lamb brain tissue. Finally, the method was satisfactorily applied to 14 cerebral cortex samples collected from SIUDS and SIDS victims in the 2012–2014 period.
Experimental
Chemicals and reagents
A mix of OCPs (certified reference material) containing α-BHC, β-BHC, γ-BHC, δ-BHC, aldrin, α-chlordane, γ-chlordane, p,p′-DDE, p,p′-DDT, p,p′-DDD, α-endosulfan, β-endosulfan, endosulfan sulfate, endrin aldehyde, endrin ketone, heptachlor, heptachlor epoxide, dieldrin, endrin, and methoxychlor in toluene–n-hexane (50:50, v/v) at a concentration of 2,000 ng μL-1 (Environmental Protection Agency Contract Laboratory Program OCP pesticide mix) was purchased from Sigma-Aldrich (Milan, Italy). Chlorpyrifos, chlorfenvinfos, and boscalid (purity greater than 99 %) were obtained from Fluka (Milan, Italy). Five isotopically labeled compounds used as internal standards—BPA-D 16, p,p′-DDE-D 8, p,p′-DDT-D 8, methoxychlor-D 14, and chlorfenvinfos-D 10—were supplied by Dr. Ehrenstorfer (Augsburg, Germany). All solvents used (n-hexane, acetone, and toluene) were pesticide residue GC-grade PESTANAL (purity greater than 99.8 %), supplied by Fluka (Milan, Italy). The chemical structures of the compounds investigated are shown in Fig. S1. The Supelclean ENVI-Florisil solid-phase extraction cleanup cartridges (200 mg/3 mL) were purchased from Phenomenex (Bologna, Italy).
Standard solutions
A diluted solution of OCPs in n-hexane–toluene (50:50, v/v) was prepared at a concentration of 100 ng μL-1. Stock standard solutions of each internal standard were prepared in acetone at a concentration of 100 ng μL-1. The working standard solutions containing all the compounds investigated were prepared by diluting the stock solutions in n-hexane. All the solutions were stored in brown glass vials at 4 °C.
Brain sample collection and storage
For ethical reasons and because of the scarce availability of control cases (fetuses or newborns that died of evident causes unrelated to environmental contamination), all validation experiments were conducted using lamb cerebral cortex. Differences in the matrix composition compared with the corresponding human tissue are negligible in terms of extraction efficiency and other interactions that may influence the quality of the analytical data, as demonstrated in the literature [47]. Lamb brain was purchased from a local supermarket, cut into 0.5-g samples, and stored at -20 °C.
Ten SIUDS cerebral cortex (25–41 weeks of pregnancy) and four SIDS cerebral cortex (2 days to 4 months of age) samples were collected during autopsies performed in several hospitals in northern Italy over a 2-year period (2012–2014) (Table 1). The autopsies were performed in all cases according to the International Standardized Autopsy Protocol of the Global Strategy Task Force of SIDS International [49] and the neuropathology protocol developed at the Department of Surgical, Reconstructive, and Diagnostic Sciences (University of Milan, Italy) [47, 48, 50]. Once in the laboratory, the specimens were accurately weighed in 0.5-g amounts, when possible, and were preserved at –20 °C before analyses. All available information about pregnancy, fetal development, delivery, exposure to environmental pollution, and familial situation was collected. For SIDS cases, information regarding death circumstances was evaluated as well.
Preparation of spiked samples
Samples of 0.5 g of frozen lamb brain were finely minced. When defrosted, each sample was spiked with a 2.5 μL of a standard solution of the selected compounds in acetone at three different concentrations—0.2, 2.0, and 10.0 ng μL-1—to obtain the following fortified concentrations in the tissues: 1.0, 10.0, and 50.0 ng g-1. Then, 3.7 μL of the 20 ng μL-1 working solution of the internal standards in acetone was added to each sample to obtain a final concentration of 150 ng g-1. The spiked samples of brain were homogenized in a glass centrifuge tube, using a Teflon tip, for 5 min and were left for 2 h at room temperature, prior to extraction, to allow solvent evaporation and better distribution of the selected compounds and internal standards throughout the matrix. The same procedure was applied to the human samples, which of course were spiked only with the internal standards.
Extraction method
The homogenate was extracted by adding 1.5 mL of n-hexane and vigorously shaken with a vortex mixer (Super Mixer, Continental Instrument, USA) for 10 min. The whole homogenate was collected and centrifuged at 3,500 rpm for 5 min. After centrifugation, the supernatant was purified through a Florisil cartridge, previously conditioned with 2 mL of n-hexane, and was collected in a glass vial. Then, the sample was concentrated to 200 μL under nitrogen. Finally, 1 μL of extract was injected into the GC–MS/MS system.
GC–MS/MS instrumentation
A GC system (Agilent 7890B, Agilent Technologies, Palo Alto, CA, USA) was coupled to a QqQ mass spectrometer (Agilent 7000A, Agilent Technologies, Palo Alto, CA, USA) operating in electron ionization mode. The GC separation was performed using a fused-silica HP-5MS capillary column (30 m × 0.25-mm inner diameter) with a film thickness of 0.25 mm (Agilent J&W GC column, Agilent Technologies, Folsom, CA, USA). The oven temperature was set as follows: 80 °C (1 min), up to 180 °C at 30 °C min-1; up to 225 at 3 °C min-1 (held for 4 min), then up to 300 °C at 20 °C min-1 (held for 1.08 min). The injector was set at 250 °C, operating in splitless mode using helium (purity 99.9 %; Air Liquide, Milan, Italy) as the carrier gas at a constant flow rate of 1 mL min-1. The interface and the ion source temperature were kept at 290 °C and 300 °C, respectively. The QqQ MS system operated in MRM mode using nitrogen (purity 99.9 %) as the collision gas at a flow rate of 1.5 mL min-1 in the collision cell. Helium was used as the quenching gas in the collision cell at a flow rate of 2.2 mL min-1. The filament current was set at 35 μA. MS spectra (scan range m/z 50–550, scan time 200 ms, 6.1 cycles per second) and MS/MS spectra (scan range m/z 50–400, 4.2 cycles per second) were acquired for each analyte in order to select the best precursor and product ions for MRM experiments. The retention times, precursor and product ions, and optimized collision energy for each analyte are listed in Table 2. Data acquisition and analyses were performed using the Agilent MassHunter Workstation software package supplied by Agilent Technologies. The MassHunter Quantitative Analysis program was used to process the quantitative data obtained from calibration matrices and from real samples.
Results and discussion
MS/MS optimization
Optimization of the MS/MS method was performed for all selected compounds using standard solutions in n-hexane. The full-scan spectra were obtained by injecting a 100 pg μL-1 standard mixture. The precursor ions of every compound were selected as the most abundant peaks of each spectrum. Different collision energies (from 15 to 30 eV) were tested to perform the fragmentation. For each compound, the collision energies that yielded the two precursor–two product ion transitions with the best signal intensity were chosen to build the MRM acquisition method. When this was not possible, two transitions from one precursor ion were used. The most intense transition was chosen as a quantifier (Q) and the second most intense transition was chosen as a qualifier (q), using the ion ratio criteria established by Commission Decision 2002/657/EC [51]. At least two transitions per compound were selected, with the exception of internal standards, which required only one transition, normally the most intense one. The Q and q transitions selected for every compound are shown in Table 2. The optimized collision energies and Q/q ratios are also listed in Table 2. Average Q/q ratios, obtained from standard solutions at three concentrations (50, 100, 200 pg μL-1) each injected in triplicate (n = 9), were kept as “theoretical values” and are also shown in Table 2. Satisfactory relative standard deviation of 15 % or less was achieved for all the compounds.
The dwell time was also optimized in order to obtain a good chromatographic peak. This parameter gave the best results for all compounds in the range from 0.01 and 0.7 s.
Confirmation ratio
The Q/q ratio was used to confirm peak identity in the real and spiked samples. The experimental Q/q ratios, obtained from real samples, were compared with the theoretical ones. Confirmation of analytes detected in real samples was considered positive when the experimental Q/q ratio was within ±20 % of the average Q/q value calculated from the standards, as established in Commission Decision 2002/657/EC [51]. This decision was originally defined for the determination of organic contaminants in food samples, although it is being increasingly used for the confirmation of positive findings in other matrices [52, 53]. These ratios, together with the retention time, provided unequivocal identification of the selected compounds.
In the case of complex matrices, such as brain, the use of MS/MS mode is very important to notably increase sensitivity and selectivity, allowing one to discriminate between many interfering compounds coming from the matrix which are not removed by the cleanup procedure.
Method validation
Validation of the method considered the following parameters: LOD, limit of quantification (LOQ), linearity (R 2), intraday repeatability, interday repeatability, trueness (recovery), and precision. The LODs were defined as a signal-to-noise ratio of 3 or more for the less intense (confirmation) MRM transition. They ranged from 0.03 to 0.1 ng g-1 for each compound (Table 3). The LOQs (signal-to-noise ratio of 10 or more) ranged from 0.2 to 0.6 ng g-1(Table 3). Thus, the analytical method proved to be sensitive enough.
Linearity
The method linearity was evaluated using samples (0.5 g) of lamb cerebral cortex. All samples were previously tested to assess the absence of the selected compounds. This procedure was applied to each brain sample batch used to validate the method. Samples of blank tissues were fortified at seven concentrations ranging between 0.2 and 200 ng g-1, as established in Commission Decision 2002/657/EC [51]. The first four levels of calibration (0.2, 2.0, 10.0, 20.0 ng g-1) were chosen to give more importance to the low concentrations, as suggested by Antignac et al. [52]. Each concentration was injected in triplicate. Internal standard linear calibration curves were plotted by least-squares regression of concentration versus the relative peak area (analyte/internal standard) of the calibration standards. Adequate linearity values, calculated as a determination coefficient (R 2) higher than 0.9940, were obtained for all compounds (Table 3).
Trueness and precision
Trueness (recovery) and precision were evaluated by means of recovery experiments (n = 9) at three concentrations (1, 10, 50 ng g-1). This range of concentrations was chosen since it was close to the expected concentrations in real samples. Each lamb matrix was spiked and extracted three times. As can be observed in Fig. 1, the histogram shows that most compounds had satisfactory recoveries, with values ranging between 70 and 120 % at the three fortification levels. Precision was expressed as the intraday and interday repeatability (relative standard deviation). The intraday repeatability was estimated at each fortification level from the recovery experiments (n = 3). A 50 pg μL-1 standard solution was prepared daily for the interday repeatability studies, and five injections were made for each day (5 days, n = 25). The intraday repeatability ranged from 2 to 6 % for all injected concentrations and the interday repeatability ranged from 8 to 18 %. The results obtained indicate the good repeatability and accuracy of the proposed method.
Application to real samples
Highly selective detectors such as MS/MS analyzers are recommended in the analysis of complex matrices. They allow one to discriminate between the interferences coming from the matrix (i.e., biological tissues) which are not eliminated by the cleanup procedure and to identify and quantify analytes even at very low concentrations. The use of MRM mode permits the monitoring of specific transitions (specific precursor and product ions), and is able to unequivocally detect all compounds of interest. The method was applied to the analysis of 14 human cerebral cortexes coming from ten SIUDS and four SIDS victims. The presence of some environmental contaminants detected in eight positive samples from 14 fetal and neonatal brain tissues, as reported in Table 4, could lead to the possibility that they can pass from mother to fetus and can be collected in the brain tissue. This is in accordance with literature data that report the presence of the selected pollutants in other human tissues [53–55]. It is very interesting to note that four brain samples showed the presence at parts per billion levels of several OCPs and three samples evidenced the presence of two OPPs—chlorpyrifos and chlorfenvinfos—the commonest pesticides used for many crops, such as apples and grapes, in several Italian regions. Even though these compounds are environmentally nonpersistent, their extensive use in pest control exposes the population to continuous low-level concentrations. The very low concentrations of some contaminants found in a few samples can be of great concern owing to the delicacy of fetal and newborn tissues. As a reference, for an adult, the acceptable daily intake of these compounds ranges from 0.002 to 0.02 mg per kilogram of body weight.
As regards the confirmation of positive findings, all the compounds with a high concentration (above the LOQ) as well as those detected at low concentration (between the LOD and the LOQ) were confirmed by the use of the two transitions selected, the compliance of Q/q ratios, and retention times. As an example, Fig. 2 shows the MS/MS chromatograms, with relative experimental Q/q ratios, for two of the compounds detected in two brain samples from SIDS (Fig. 2a, case N12) and SIUDS (Fig. 2b, case F11) victims, respectively. The Q/q ratios calculated for all positive samples were within the range of the tolerance accepted around the experimental average Q/q value obtained from reference standards. The application of this method allowed the quantification and confirmation of all selected compounds at the 0.2–0.6 ng g-1 level. The use of MS/MS in QqQ instruments working in MRM mode permits the rapid, efficient, and sensitive confirmation of these environmental contaminants.
Conclusions
A GC–MS/MS method for quantification and confirmation of selected environmental contaminants in human fetal and newborn brain tissues has been proposed. The use of a QqQ analyzer, working in MRM mode, allowed us to achieve excellent selectivity and sensitivity compared with our previous work. The selectivity was improved by recording two transitions, with two different precursor ions, for most of the analytes. The ratios obtained from them were used as confirmatory parameters, together with the retention time. The application of this method to a real matrix allowed the quantification and confirmation of all selected compounds at the 0.2–0.6 ng/g level. Finally, the method was applied to 14 real samples from ten SIUDS and four SIDS victims. Even though the selected contaminants were detected only at low parts per billion levels, the assessment of possible fetal and newborn exposures, together with the determination of these compounds in fetal and newborn tissues, is a critical factor to establish a potential correlation with sudden death syndromes.
The method will allow future developments in establishing a possible correlation between environmental contaminants and the syndromes. In fact, it is a robust platform for the analysis of a large number of samples and offers the possibility to extend the study to other classes of pollutants such as polychlorinated biphenyls and phthalates.
References
Kandall SR, Gaines J, Habel L, Davidson G, Jessop D (1993) Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr 123:120–126
Fares I, McCulloch KM, Raju TN (1997) Intrauterine cocaine exposures and the risk for sudden infant death syndrome: a meta analysis. J Perinatol 17:179–182
Klonoff-Cohen HS, Leigh Edelstein S, Schneider Lefkowit E, Srinivasan IP, Kaegi D, Chun Chang J, Wiley KJ (1995) The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA 273:795–798
Adgent MA (2006) Environmental tobacco smoke and sudden infant death syndrome: a review. Birth Defects Res B Dev Reprod Toxicol 77:69–85
Lavezzi AM, Mecchia D, Matturri L (2012) Neuropathology of the area postrema in sudden intrauterine and infant death syndromes related to tobacco smoke exposure. Auton Neurosci 166:29–34
Lavezzi AM, Corna MF, Alfonsi G, Matturri L (2014) Possible role of the α7 nicotinic receptors in mediating nicotine’s effect on developing lung – implications in unexplained human perinatal death. BMC Pulm Med 14:11. doi:10.1186/1471-2466-14-11
Lavezzi AM, Ottaviani G, Matturri L (2005) Adverse effects of prenatal tobacco smoke exposure on biological parameters of the developing brainstem. Neurobiol Dis 20:601–607
Bauchnera H, Zuckermana B, McClaina M, Franka D, Frieda LE, Kaynea H (1988) Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr 113:831–834
United Nations Environment Program (2008) Stockholm Convention on Persistent Organic Pollutants (POPs). http://chm.pops.int/TheConvention/Overview/TextoftheConvention/tabid/2232/Default.aspx
Axmon A, Rylander L, Strömberg U, Hagmar L (2000) Miscarriages and stillbirths in women with a high intake of fish contaminated with persistent organochlorine compounds. Int Arch Occup Environ Health 73:204–208
Bergonzi R, De Palma G, Specchia C, Dinolfo M, Tomasi C (2011) Persistent organochlorine compounds in fetal and maternal tissues: evaluation of their potential influence on several indicators of fetal growth and health. Sci Total Environ 409:2888–2893
Lopez Espinosa MJ, Murcia M, Iniguez C, Vizcaino N, Llop S, Vioque J, Grimalt JO, Rebagliato M, Ballester F (2011) Prenatal exposure to organochlorine compounds and birth size. Pediatrics 128:e1–e8
Rylander L, Stromberg U, Hagmar L (2000) Lowered birth weight among infants born to women with high intake of fish contaminated with persistent organochlorine compounds. Chemosphere 40:1255–1262
Longnecker MP, Klebanoff MA, Zhou H, Brock JW (2001) Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. Lancet 358:110–114
Siddiqui MKJ, Srivastava S, Srivastava SP, Mehrotra PK, Mathur N, Tandon I (2003) Persistent chlorinated pesticides and intra-uterine foetal growth retardation: a possible association. Int Arch Occup Environ Health 76:75–80
Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N (1999) Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age. J Pediatr 134:33–41
Asawasinsopon R, Prapamontol T, Prakobvitayakit O, Vaneesorn Y, Mangklabruks A, Hock B (2006) The association between organochlorine and thyroid hormone levels in cord serum: a study from northern Thailand. Environ Int 32:554–559
Myllynen P, Pasanen M, Pelkonen O (2005) Human placenta: a human organ for developmental toxicology research biomonitoring. Placenta 26:361–371
Barr DB, Bishop A, Needham LL (2007) Concentrations of xenobiotic chemicals in the maternal-fetal unit. Reprod Toxicol 23:260–266
Herrero-Mercado M, Waliszewski SM, Caba M, Martinez-Valenzuela C, Gòmez Arroyo S, Villalobos Pietrini R, Cantù Martinez PC, Hèrnandez-Chalate F (2011) Organochlorine pesticide gradient levels among maternal adipose tissue, maternal blood serum and umbilical blood serum. Bull Environ Contam Toxicol 86:289–293
Mustafa MD, Pathak R, Tripathi AK, Ahmed RS, Guleira K, Banerjee BD (2010) Maternal and cord blood levels of aldrin and dieldrin in Delhi population. Environ Monit Asses 171:633–638
Fukata H, Omori M, Osada H, Todaka E, Mori C (2005) Necessity to measure PCBs and organochlorine pesticide concentrations in human umbilical cords for fetal exposure assessment. Environ Health Perspect 113:297–303
Bergonzi R, Specchia C, Dinilfo M, Tomasi C, De Palma G, Frusca T, Apostoli P (2009) Distribution of persistent organochlorine pollutants in maternal and foetal tissues: data from an Italian pollute urban area. Chemosphere 76:747–754
Shen H, Main KM, Virtanen HE, Damggard IN, Haavisto AM, Kaleva M (2007) From mother to child: investigation of prenatal and postnatal exposure to persistent bioaccumuling toxicants using breast milk and placenta biomonitoring. Chemosphere 67:S256–S262
Oehlmann J, Schulte-Oehlmann U, Kloas W, Jagnytsch O, Lutz I, Kusk K, Wollenberger L, Santos EM, Paull GC, Van Look KJ, Tyler CR (2009) A critical analysis of the biological impacts of plasticizers on wildlife. Philos Trans R Soc B 364:2047–2062
Engel SM, Wetmur J, Chen J, Zhu C, Barr DB, Canfield RL, Wolff MS (2011) Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect 119:1182–1188
Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N (2011) Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect 119:1189–1195
Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ (2007) Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am J Epidemiol 165:1397–1404
Rauh V, Arunajadai S, Horton M, Perera F, Hoepner L, Barr DB, Whyatt R (2011) Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect 119:1196–1201
Rauch SA, Braun JM, Barr DB, Calafat AM, Khoury J, Montesano MA, Yolton K, Lanphear PL (2012) Associations of prenatal exposure to organophosphate pesticide metabolites with gestational age and birth weight. Environ Health Perspect 120:1055–1060
Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, Khoury J (2011) Prenatal exposure to bisphenol A and phthalates and infant neurobehaviour. Neurotoxicol Teratol 33:558–566
Richardson RJ (1995) Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 44:135–165
Whyatt RM, Camann D, Perera FP, Rauh VA, Tang D, Kinney PL et al (2005) Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol 206:246–254
Doucet J, Tague B, Arnold DL, Cooke GM, Hayward S, Goodyer CG (2009) Persistent organic pollutant residues in human fetal liver and placenta from Greater Montreal, Quebec: a longitudinal study from 1998 through 2006. Environ Health Perspect 117:605–610
Porpora MG, Lucchini R, Abballe A, Ingelido AM, Valentini S, Fuggetta E (2013) Placental transfer of persistent organic pollutants: a preliminary study on mother-newborn pairs. Int J Environ Res Public Health 10:669–711
Rawn D, Gaertner D, Sun W, Casey V, Curran I, Cooker G et al (2011) Polybrominated diphenyl ethers (PBDEs) in Canadian human fetal liver and placental tissues. Organohalogen Compd 73:563–566
Schecter A, Johnson-Welch S, Tung KC, Harris R, Papke O, Rosen R (2007) Polybrominated diphenyl ether (PBDE) levels in livers of U.S. human fetuses and newborns. J Toxicol Environ Health 70:1–6
Zhao Y, Ruan X, Li Y, Yan M, Qin Z (2013) Polybrominated diphenyl ethers (PDBEs) in aborted human fetuses and placental transfer during the first trimester of pregnancy. Environ Sci Technol 47:5939–5946
Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Curran ME, Silvestri JM, Marazita ML (2004) Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res 56:391–395
Matturri L, Lavezzi AM (2011) Unexplained stillbirth versus SIDS: common congenital diseases of the autonomic nervous system-pathology and nosology. Early Hum Dev 87:209–215
Cappiello A, Famiglini G, Palma P, Termopoli V, Lavezzi AM, Matturri L (2014) Determination of selected endocrine disrupting compounds in human fetal and newborn tissues by GC-MS. Anal Bioanal Chem 406:2279–2288
Decreto 23 luglio 2008 (GU n.265 del 12/11/2008). Rome, Italy
European Commission (2008) Commission Regulation (EC) No 839/2008 of 31 July 2008 amending Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards Annexes II, III and IV on maximum residue levels of pesticides in or on certain products. Off J Eur Union L 234:1–216
de Hoffmann E, Stroobant V (2002) Mass spectrometry, principles and Application, 2nd edn. Wiley, New York
Law 31 - February 2, 2006 “Regulations for diagnostic postmortem investigation in victims of the sudden infant death syndrome (SIDS) and unexpected fetal death” published in Gazzetta Ufficiale no. 34 - February 10, 2006
Matturri L, Ottaviani G, Lavezzi AM (2005) Techniques and criteria in pathologic and forensic-medical diagnostics of sudden unexpected infant and perinatal death. Am J Clin Pathol 124:259–268
Matturri L, Ottaviani G, Lavezzi AM (2008) Guidelines for neuropathologic diagnostics of perinatal unexpected loss and sudden infant death syndrome (SIDS)—a technical protocol. Virchows Arch 452:19–25
Cartiser N, Bévalot F, Le Meur C, Gaillard Y, Malicier D, Hubert D, Guitton J (2011) Gas chromatography–tandem mass spectrometry assay for the quantification of four benzodiazepines and citalopram in eleven postmortem rabbit fluids and tissues, with application to animal and human samples. J Chromatrogr B 879:2909–2918
Krous HF (1996) Instructions and reference manual for the International Standardize Autopsy Protocol for sudden unexpected infant death. J SIDS Infant Mortal 1:203–246
European Commission (2002) 2002/657/EC: Commission Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Communities L 221:8–36
Antignac JP, Le Bizec B, Monteau F, Andre F (2003) Validation of analytical methods based on mass spectrometric detection according to the “2002/657/EC” European Decision: guideline and application. Anal Chim Acta 483:325–334
Medina CM, Pitarch E, Portolès T, Lòpez FJ, Hèrnandez F (2009) GC-MS/MS multi-residue method for the determination of organochlorine pesticides, polychlorinated biphenyl ethers in human breast tissues. J Sep Sci 32:2090–2012
Chu S, Covaci A, Schepens P (2003) Levels and chiral signatures of persistent organochlorine pollutants in human tissues from Belgium. Environ Res 93:167–176
Hernandez F, Sancho JV, Pozo O (2005) Critical review of the application of liquid chromatography/mass spectrometry to the determination of pesticide residues in biological samples. J Anal Bioanal Chem 382:934–946
Acknowledgments
The authors thank Agilent Technologies for providing the GC–MS/MS instrument. We are very grateful to all the personnel in the pathology units of Rovereto, Lecco, and Modena hospitals for providing SIUDS and SIDS autopsy samples.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
Occurrence of specific environmental risk factors in brain tissues of sudden infant death and sudden intrauterine unexpected death victims assessed with gas chromatography–tandem mass spectrometry (PDF 70 kb)
Rights and permissions
About this article
Cite this article
Termopoli, V., Famiglini, G., Palma, P. et al. Occurrence of specific environmental risk factors in brain tissues of sudden infant death and sudden intrauterine unexpected death victims assessed with gas chromatography–tandem mass spectrometry. Anal Bioanal Chem 407, 2463–2472 (2015). https://doi.org/10.1007/s00216-015-8492-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-015-8492-x